GlassScriptPhysician profile
Amy L Ingram
NPI 1588894653
$6,923.25
in general payments reported to CMS, 2019-2025
30 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $609 · 2021: $1,806 · 2022: $1,813 · 2023: $594 · 2024: $1,068 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,129.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,224.40 | 2020-2024 | Halo, Coblation, Tula |
| Inspire Medical Systems, INC. | $1,135.57 | 2019-2025 | Inspire |
| Optinose US, INC. | $532.83 | 2019-2023 | |
| Stryker Corporation | $413.07 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $410.41 | 2019-2024 | Dupixent |
| Csl Behring | $363.98 | 2020-2024 | Haegarda, Hizentra |
| Glaxosmithkline, LLC. | $246.69 | 2022-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $180.14 | 2023-2024 | |
| Integra Lifesciences Corporation | $150.00 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Hologic Sales and Service, LLC | $144.45 | 2022 | |
| Preceptis Medical, INC. | $144.40 | 2024 | Hummingbird Tympanostomy Tube System |
| Biohaven Pharmaceutical Holding Company LTD. | $143.08 | 2022 | |
| Medtronic, INC. | $114.21 | 2021 | |
| Lucid Diagnostics INC. | $91.82 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $84.21 | 2020-2023 | Fasenra |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $79.67 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $74.50 | 2021-2022 | |
| Lilly USA, LLC | $58.29 | 2025 | Zepbound |
| Resmed Corp | $53.76 | 2020 | |
| Amgen INC. | $45.47 | 2021-2023 | Tezspire |
| Pfizer INC. | $45.35 | 2023-2025 | |
| Aerin Medical INC. | $32.20 | 2022-2023 | |
| Kaleo, INC. | $29.94 | 2020-2021 | |
| Itamar Medical INC | $24.18 | 2023 | Watchpatone |
| Phathom Pharmaceuticals, INC. | $18.97 | 2025 | Voquezna |
| Octapharma USA, INC. | $18.36 | 2022 | |
| Alk-Abello, INC | $16.74 | 2021 | |
| Abbvie INC. | $16.45 | 2025 | |
| Hikma Pharmaceuticals USA | $15.90 | 2023 | Ryaltris |
| Neurent Medical Limited | $14.21 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.